Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Routine proctosigmoidoscopy: how often?

J Drexler

    Oncology
    |January 1, 1974
    PubMed
    Summary
    This summary is machine-generated.

    Routine proctosigmoidoscopy screening can be improved by focusing on high-risk patients. Repeat examinations every 2-6 years for specific groups enhance safety and productivity in colon cancer detection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ready reminders.

    Occupational health & safety (Waco, Tex.)·2001
    Same author

    Respirable particles in the excimer laser plume.

    Journal of cataract and refractive surgery·2001
    Same author

    Bioavailability of soilborne lead in adults, by stable isotope dilution.

    Environmental health perspectives·1998
    Same author

    Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.

    European journal of immunology·1995
    Same author

    Epitope-specific enhancement of antigen presentation by invariant chain.

    The Journal of experimental medicine·1993
    Same author

    Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines.

    International immunology·1993
    Same journal

    Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar.

    Oncology·2026
    Same journal

    SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

    Oncology·2026
    Same journal

    Letter to the Editor.

    Oncology·2026
    Same journal

    FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

    Oncology·2026
    Same journal

    Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

    Oncology·2026
    Same journal

    Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

    Oncology·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Preventive Medicine
    • Oncology

    Background:

    • Routine proctosigmoidoscopy screening effectiveness can be enhanced.
    • Identifying high-risk patient groups is crucial for optimizing screening protocols.

    Purpose of the Study:

    • To evaluate the cost-yield performance of proctosigmoidoscopy.
    • To determine optimal screening intervals for different risk groups.

    Main Methods:

    • Analysis of proctosigmoidoscopy data focusing on patient risk stratification.
    • Comparison of screening outcomes based on polyp status and examination frequency.

    Main Results:

    • Limiting examinations to higher-risk patients improves cost-yield.
    • Patients with diminutive polyps are at increased risk.

    Related Experiment Videos

  • Over 35% of patients with an initial negative screening developed new polyps within 6 years.

    • Conclusions:

    • Proctosigmoidoscopy every 2 years is safe and productive for higher-risk patients, including those with diminutive polyps.
    • Repeat proctosigmoidoscopy at least every 6 years is warranted for patients with no initial polyps.